Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis
The current meta-analysis analyzed the prognostic impact of elevated platelet count before the treatment of malignant mesothelioma (MM). We performed a search for articles published up to April 15, 2016 in PubMed, MEDLINE, EMBASE, and Web of Science, which evaluated elevated platelet count and survi...
Main Authors: | Yi Zhuo, Lanying Lin, Mingwei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-08-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2016.1246712 |
Similar Items
-
Prognostic significance of thrombocytosis in lung cancer: a systematic review and meta-analysis
by: Yunfei Ma, et al.
Published: (2021-10-01) -
Prognostic factors for progression‐free and overall survival in malignant pleural mesothelioma
by: Jordi Guzmán‐Casta, et al.
Published: (2021-04-01) -
Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
by: Jian-Guo Zhou, et al.
Published: (2019-02-01) -
Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis
by: Bai YY, et al.
Published: (2019-05-01) -
Prognostic value of clinicopathological characteristic of patients with Malign Mesothelioma at Mediternean region of Turkey
by: Erkan Kayıkçıoğlu, et al.
Published: (2022-11-01)